Prescription Drug Monitoring Program

Legislative Audit Committee. Sections 1 and 2 of the bill clarify that each licensed health-care practitioner must query the prescription drug monitoring program (program) prior to filling a prescription for every opioid or benzodiazepine.Section 3 requires the group tasked with developing a strategic plan to reduce prescription drug misuse to also make recommendations to the executive director of the department of regulatory agencies concerning balancing the use of the program as a health-care tool with enforcement of the requirements of the program.
(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)